[Scintigraphic images im primary hyperparathyroidism with 99m Tc-Tetrofosmin]

Area of Science:

• Nuclear Medicine
• Endocrinology
• Oncology

Background:

• Primary hyperparathyroidism is characterized by elevated calcium and parathyroid hormone (PTH) levels.
• Accurate localization of parathyroid lesions is crucial for surgical planning.

Purpose of the Study:

• To evaluate the diagnostic utility of 99mTc-tetrofosmin scintigraphy in primary hyperparathyroidism.
• To compare the effectiveness of early versus delayed imaging in detecting parathyroid abnormalities.

Main Methods:

• Eight patients with clinical and laboratory evidence of primary hyperparathyroidism underwent parathyroid scintigraphy.
• A 20 mCi (740 MBq) intravenous injection of 99mTc-tetrofosmin was administered, with image acquisition at 10, 60, and 120 minutes.
• All patients subsequently underwent surgery, and histological analysis confirmed parathyroid pathology.

Main Results:

• Scintigraphy revealed lesions correlating with surgical findings in all patients.
• Preferential retention of 99mTc-tetrofosmin was observed in early (10-minute) images in 100% of cases.
• Delayed (120-minute) images showed tracer retention in 62.5% of cases.

Conclusions:

• Early (10-minute) scintigraphy images demonstrate superior diagnostic value for primary hyperparathyroidism compared to delayed images.
• 99mTc-tetrofosmin scintigraphy is a valuable tool for parathyroid lesion localization.
• The imaging characteristics of 99mTc-tetrofosmin may be relevant for other tumor types.